B Lymphopoiesis in the Thymus

Koichi Akashi, Lauren I. Richie, Toshihiro Miyamoto, William H. Carr and Irving L. Weissman
J Immunol May 15, 2000, 164 (10) 5221-5226; DOI: https://doi.org/10.4049/jimmunol.164.10.5221

Abstract

The thymus has been regarded as the major site of T cell differentiation. We find that in addition to αβ and γδ T cells, a significant number (∼3 × 104 per day) of B220+IgM+ mature B cells are exported from the thymus of C57BL/6 mice. Of these emigrating B cells, we estimate that at least ∼2 × 104 per day are cells which developed intrathymically, whereas a maximum of ∼0.8 × 104 per day are cells which circulated through the thymus from the periphery. The thymus possesses a significant number of pro-B and pre-B cells that express CD19, VpreB, λ5, and pax-5. These B cell progenitors were found in the thymic cortex, whereas increasingly mature B cells were found in the corticomedullar and medullary regions. Other lymphoid cells, including NK cells and lymphoid dendritic cells, are not exported from the thymus at detectable levels. Thus, the thymus contributes to the formation of peripheral pools of B cells as well as of αβ and γδ T cells.

Thymocyte progenitors migrate from hematopoietic tissues, such as the bone marrow, to the thymus where they proliferate, mature, and undergo a stringent selection process resulting in the export of self-tolerant TCRαβ T cells and TCRγδ T cells. During their tenure in the thymus, maturing thymocytes interact with the thymic microenvironment, which provides the appropriate cellular and/or soluble factors to enable thymocyte proliferation, development, and selection. This microenvironment includes several types of thymic epithelial cells, bone marrow-derived dendritic cells, macrophages, bone marrow derived B cells, and several mesenchymal elements. Thymic epithelial cells produce a number of cytokines, including steel factor and IL-7, both of which play important roles in progenitor proliferation, survival, and commitment to the T cell lineages (1, 2). Both steel factor and IL-7 are also critical for the maturation of B cells in the bone marrow (3, 4, 5).

In early mouse fetal life, the first seeded thymic progenitors collectively include cells capable of T or B cell maturation (6, 7, 8). In adults, the thymus is continuously seeded at a low rate. These bone marrow-derived precursors have not yet been fully characterized as to their phenotype or function. One candidate is the recently identified common lymphoid progenitor (CLP),4 which has lymphoid-restricted differentiation potential into T, B, and NK cells (9), found in adult bone marrow. The CD4lowCD44highc-Kit+ earliest thymic precursor population (10) has been shown to be capable of differentiating not only into T cells but also into NK cells, B cells, and lymphoid dendritic cells at low frequencies (10, 11, 12). Therefore, one might expect to find some B cells, NK cells, and dendritic cells maturing within and emigrating from the adult thymus.

To test this hypothesis, we analyzed recent thymic emigrants (RTEs) to peripheral lymphoid organs. FITC was injected intrathymically to label cells in the thymus, and at various time points after labeling, the spleen and lymph nodes were analyzed for the presence of RTE. We found that, in addition to αβ and γδ T cells, a significant number (3 × 104 per day) of non-T cells were exported from the thymus; these were B220+IgM+ B cells. We also demonstrated that the majority of these cells were generated from precursors in the thymus, whereas a minority could have been derived from circulating B cells that had entered the thymus.

Materials and Methods

Mouse strains

The congenic strains of mice, C57BL6-Ly5.2 or C57BL6-Ly5.1 mice, were used. The C57BL6-Ly5.1/Ly5.2 mice were made by crossing C57BL6-Ly5.2 with C57BL6-Ly5.1 (F1). The strains differed only at the Ly5 allele, and this difference made it possible to detect donor-derived cells. C57BL6-TCRβ-deficient mice (13) were purchased from The Jackson Laboratory (Bar Harbor, ME). Mice were bred and maintained in the animal care facility at Stanford University School of Medicine and were used at 4–8 wk of age.

Labeling of thymocytes and flow cytometric analysis

The technique for in vivo intrathymic labeling of thymocytes with FITC has been previously described (14). Briefly, 10 μl of FITC (1 mg/ml; Sigma, St. Louis, MO) was injected into both thymic lobes of 5- to 8-wk-old C57BL/6 mice. Single-cell suspensions were made from the spleen and the lymph nodes, including cervical, axillary, submandibular, inguinal, brachial, and mesenteric lymph nodes. Cells were stained with PE or allophycocyanin-conjugated anti-IgM (clone 331; obtained from Dr. L. A. Herzenberg, Stanford University, Stanford, CA), Mac-1 (M1/70), Gr-1 (8C5), anti-CD3 (KT31.1), anti-CD4 (GK1.5), anti-CD5 (53-7.8), and/or anti-CD8 (53-6.7) Abs. Anti-IAb, anti-CD11c, anti-αβTCR, and anti-γδTCR Abs were purchased from PharMingen (San Diego, CA). In analyzing CD4−CD8− RTEs, cells were additionally stained with Texas Red-conjugated anti-CD4 and anti-CD8 Abs. For thymic B cell progenitor analysis, thymocytes were stained with FITC-conjugated anti-CD43 (S7) and anti-mouse IgD (clone 11-26; obtained from Dr. L. A. Herzenberg); PE; or Cy5-PE-conjugated anti-mouse IgM, PE-conjugated anti-CD19, allophycocyanin-conjugated B220, and Texas Red-conjugated anti-CD4 and anti-CD8 Abs (PharMingen). Cells were analyzed by a highly modified five-color FACS Vantage (Becton Dickinson, Mountain View, CA) (9). Dead cells were excluded by positive staining with propidium iodide and were detected in a Cy5-PE channel.

Estimation of mature T and B cell immigrants into the thymus

Single spleen cell suspension was obtained from C57BL6-Ly5.1/Ly5.2 mice. Myeloid spleen cells were removed by incubation with Gr-1, Mac-1, and Ter119 Abs before negative selection using anti-rat IgG-conjugated immunomagnetic beads (Dynal, Oslo, Norway). The purified 1 × 108 splenic lymphocytes from adult (Ly5.1 × Ly5.2)F1 mice were injected into 1.5- to 3-wk-old Ly5.1 mice. The percentages of donor-derived mature αβ T cells and B cells in the secondary lymphoid organs were analyzed 7, 18, and 24 days postinjection, when the injected Ly5.1 mice reached the age of 4–5 wks.

Immunohistochemical staining

Sections of the thymus were cut from frozen samples at 4 microns and were fixed with acetone for 10 min (15). Samples were treated with the Vector Avidin/Biotin Blocking Kit (Vector Laboratories, Burlingame, CA) and stained with biotinylated anti-IgM, B220, or MD2 Abs (16). They were incubated with Streptavidin HRP (Caltag, South San Francisco, CA), visualized with 3-amino-9-ethylcarbazole as the chromagen for 20 min, and counterstained with Gill’s hematoxylin (Medical Chemical, Fairfield, NJ). Isotype-matched rat IgG was used as a negative control.

RT-PCR analysis

Total RNA was isolated from 1000 purified thymic pro-B and pre-B cells. cDNA was analyzed for the presence of pax-5, VpreB, or λ5 by amplification of 36, 32, or 32 cycles, respectively. The following primers were used: pax-5-forward, CTA CAG GCT CCG TGA CGC AG; pax-5-reverse, TCT CGG CCT GTG ACA ATA GG (Tanneal, 65°C; expected length, 439 bp; Ref. 17); VpreB-forward, GTC TGA ATT CCT CCA GAG CCT AAG ATC CC; VpreB-reverse, CAG GTC TAG AGC CAT GGC CTG GAC GTC TG (Tanneal, 60°C; expected length, 400 bp; Ref. 18); λ5-forward, GGG TCT AGT GGA TGG TGT CC; and λ5-reverse, CAA AAC TGG GGC TTA GAT GG (Tanneal, 60°C; expected length, 205 bp; Ref. 19).

Results

Recent thymic emigrants include B cells as well as αβ and γδ T cells

FITC was injected intrathymically to label cells in the thymus, and the spleen and lymph nodes were later analyzed for the presence of RTE. After intrathymic FITC injection, the percentage of labeled cells in the thymus was followed over time (Fig. 1⇓A). Six hours postinjection, 95% of the thymocytes were FITC+ (Fig. 1⇓A) in comparison with noninjected controls. From 6 to 48 h postinjection, the percentage of FITC-labeled cells decreased in a nearly linear fashion. One of the main causes of the loss of FITC might be cell division, resulting in a 50% decrease in surface labeling per cell division (20), although it is possible that the loss of FITC label could be due to normal turnover of membrane proteins in the absence of division (21). As shown in Fig. 1⇓B, the intensity of FITC signals at 6 h postinjection was strong enough to detect more than 85% of FITC-labeled cells after one or two cell divisions and ∼50% of cells after four cell divisions. Because the estimated cycling time for thymocytes is ∼8–12 h (22), the majority of progeny from cycling FITC-labeled thymocytes might maintain detectable levels of FITC at least 24 h after injection. At 24 h postinjection, ∼84% of thymocytes retained detectable levels of FITC, indicating that the bulk of thymocytes can be estimated to turn over in ∼6 days. This estimate is in accordance with turnover rates of thymocytes in previous reports (23). Because only ∼1% of thymocytes emigrate per day (14), the major loss of labeled cells is likely due to apoptosis of thymocytes that either failed positive selection or were deleted by negative selection (22, 24).

FIGURE 1.
FIGURE 1.

Changes in the FITC level of thymocytes after intrathymic injection of FITC. A, Decrease in the number of FITC+ thymocytes after intrathymic injection of FITC. The vertical bars represent SD in each time point of analysis (each point represents five mice). B, Levels of FITC in thymocytes 6 h after FITC injection. ▿, Limit of FITC intensity detectable on FACS. Each vertical broken line represents a scale for a two-fold difference in FITC intensity. Therefore, the number on top of each vertical line indicates the time of cell division that allows the cells on the lines to remain detectable by FACS.

The phenotype of FITC-labeled thymic emigrants in the spleen is shown in Fig. 2⇓. Approximately 95% of FITC+ recent thymic emigrants were CD4+CD8− or CD4−CD8+ single-positive αβT cells (Fig. 2⇓A). The remaining ∼5% of FITC+ RTEs were CD4−CD8− double-negative cells that were composed of CD3+TCRγδ+ T cells, B220+IgM+ mature B cells, and some CD3+TCRγδ− T cells (Fig. 2⇓C). The majority of B220+IgM+ mature B cells expressed IgD, but only a minority were CD5+ (Fig. 2⇓C). The rate of appearance of FITC-labeled RTEs is almost linear in the periphery up to 24 h postinjection (Fig. 3⇓). The profiles of RTE in the lymph nodes were similar to those in the spleen (data not shown). Because most lymphocytes collect in the spleen and lymph nodes, it can be estimated that the thymus exports at least 1.2 × 106 αβ T cells, ∼3 × 104 γδ T cells, and ∼3 × 104 B cells per day to the periphery (Fig. 3⇓). The estimated numbers of αβ and γδ T cell emigrants are compatible with previous reports (14, 25). On the other hand, Mac-1+Gr-1+ granulocytes/macrophages, CD3−NK1.1+ NK cells, and CD8α+/−CD11c+MHC-class II+ dendritic cells were not detectable in the RTE (FITC+) fractions throughout these experiments (Fig. 2⇓C). The lack of FITC+ granulocytes/macrophages indicates that the FITC label did not leak into the circulation, and therefore, unincorporated FITC does not persist in a form that would be available for labeling newly immigrating or circulating cells.

FIGURE 2.
FIGURE 2.

Analysis of FITC+ recent thymic emigrants in the spleen 24 h after intrathymic injection of FITC. A, FITC+ spleen cells contain CD4−CD8− cells as well as CD4+CD8− and CD4−CD8+ single-positive mature T cells. B, Gate for the FITC+CD4−CD8− cells. C, Surface phenotypes of the FITC+CD4−CD8− cells.

FIGURE 3.
FIGURE 3.

Numbers of FITC+ αβ T (A), γδ T (B), and B cell (C) emigrants in the spleen and lymph nodes. The vertical bars represent SD in each time point of analysis (each point represents five mice).

A significant fraction of B cells that are exported from the thymus developed in the thymus

It is important to know whether the export of B cells from thymus reflects B cell production in the thymus or results from FITC labeling of B cells that have migrated into the thymus from the periphery. We tested whether or not peripheral B cells could reenter the thymus and contribute to the thymic B cell pool. We injected i.v. 1 × 108 splenic lymphocytes from adult (Ly5.1 × Ly5.2)F1 mice into Ly5.1 mice and evaluated the percentages of donor-derived mature αβ T cells and B cells in the secondary lymphoid organs 7, 18, and 24 days postinjection. The peak chimerism for donor-derived cells was seen at 18 days postinjection. Approximately 4% of αβ T cells in peripheral organs were of donor origin, whereas only 0.01% of mature αβ T cells in the thymus were of donor origin (Table I⇓). The rare reentry of these T cells into the thymus is compatible with previous reports (26, 27). On the other hand, ∼5–7% of B cells in peripheral organs were of donor origin, whereas only ∼0.6% of thymic mature B cells were of donor origin (Table I⇓ and Fig. 4⇓). If 100% of peripheral B cells could be replaced by donor-derived B cells, then 0.6 × (100/5∼7) = 12∼15% of thymic B cells could be replaced by B cells of donor origin. Therefore, a maximum of (12∼15%) × (∼5 × 104) = 0.6∼0.8 × 104 thymic B cells could have migrated from the periphery. Even if all such B cell immigrants could leave the thymus in 1 day, a maximum of 3 × 104 − 0.8 × 104 = ∼2 × 104 thymic B cell emigrants that developed intrathymically would be exported each day.

FIGURE 4.
FIGURE 4.

Donor-derived mature B cells (Ly5.1+Ly5.2+) in lymphoid organs 18 days after injection of mature splenic lymphocytes into 2-wk-old mice (Ly5.1+Ly5.2−). Percentages of donor-type B220+IgM+ B cells (Ly5.1+Ly5.2+) are 5–7% in lymph nodes, blood, and spleen but only 0.6% in the thymus. Data from a representative mouse are shown (see Table I⇓).

View this table:
Table I.

Chimerism of mature T and B cells 18 days after injection of mature lymphocytesa

B cell progenitors in the thymus

It has been reported that B cell progenitors are present in the thymus and that isolated thymic B cell progenitors can intrathymically differentiate into mature B cells after reinjection into the thymus (28). The phenotype of thymic B cell progenitors is similar to that of bone marrow B cell progenitors (29). In the C57BL/6 strain, the thymus contains significant numbers of immature B220+CD43−IgM− pre-B cells (∼1.8 × 104/thymus) and B220+CD43+IgM− pro-B cells (∼1.2 × 104/thymus) (Fig. 5⇓A and Table II⇓). These thymic B220+ B cell progenitors coexpressed CD19 but not NK1.1 (Fig. 5⇓B). The thymic IgM+ B cells were composed of IgD− and IgD+ B cells as in bone marrow B cells. Although thymic B cells are reported to express a broad range of CD5 in the C3H mouse strain (28, 30, 31), CD5 expression was almost limited to the pro-B cell fraction in the C57BL/6 strain thymi (Fig. 5⇓B).

FIGURE 5.
FIGURE 5.

Phenotypic analysis of thymic B cell compartments in either C57BL/6- or C57BL/6-TCRβ-deficient mice. A, B220/IgM profiles of CD4−CD8− thymocytes (upper panels) and B220/CD43 profiles of CD4−CD8−IgM− thymocytes (lower panels). B, Additional surface phenotypic analysis of thymic B cell progenitors: the CD19/CD43 (a) and CD5/CD43 (b) profiles of B220+IgM− cells, the B220/NK1.1 profile of CD4−CD8− cells, and the IgM/IgD profile of B220+ cells.

View this table:
Table II.

Numbers and frequencies of B cell compartments in the thymus

The thymic pro-B and pre-B cells were purified and analyzed for expression of early B cell-related molecules such as VpreB and λ5 as well as a transcription factor, pax-5. All of these were detectable in the thymic pro-B cells and were increasingly expressed in pre-B cells (Fig. 6⇓). The expression pattern of these molecules was consistent with that in bone marrow pro-B and pre-B cells (data not shown).

FIGURE 6.
FIGURE 6.

RT-PCR analysis of sorted thymic B cell progenitors. The sorted CD4−CD8−IgM−B220+CD43+ pro-B cells and CD4−CD8−IgM−-B220+CD43− pre-B cells increasingly expressed pax-5, VpreB, and λ5.

Thymic B lymphopoiesis was significantly enhanced in C57BL/6-TCRβ-deficient mice in which thymic T cell development is impaired. The TCRβ-deficient thymi had more than a 100-fold increase in the frequencies (Fig. 5⇑A) and more than a 10-fold increase in absolute numbers of both mature B cells and B cell progenitors in comparison to wild-type thymi (Table II⇑).

In immunohistochemical stainings of normal and TCRβ-deficient thymi, IgM+ B cells reside mainly in the corticomedullar junction and in the medulla, whereas B220+ cells were found throughout the thymus, indicating that immature B220+IgM− B cells mainly reside in the cortex through the corticomedullar junction (Fig. 7⇓). Accordingly, thymic B lymphopoiesis might occur concomitantly with B cell progenitor migration from the cortex to the medulla of the thymus, mirroring T lymphopoiesis (32).

FIGURE 7.
FIGURE 7.

Immunohistochemical staining of a TCRβ-deficient thymus. The thymus from a TCRβ-deficient mouse was stained with MD-2 Abs that react with medullar epithelial cells (A), B220 Abs (B), and anti-IgM Abs (C). Cx, Cortex; M, medulla.

Discussion

We demonstrate that the adult C57BL mouse thymus physiologically generates and exports a significant number of B cells into the peripheral B cell pool. The findings of B cell development in the thymus and the recently described αβ T cell development in the bone marrow (33, 34) challenge the paradigm of lymphocyte classification into bone marrow-derived B cells and thymus-derived T cells. Our study also suggests that the thymus may not actively export NK cells and dendritic cells into the periphery or that the level of export may be below the level of detection in this study.

The thymus possesses B cell progenitors of each stage that are similar to those in bone marrow. This suggests that the thymic microenvironment can fully support B as well as T cell maturation. Adult thymi have been shown to be capable of generating B cells after intrathymic injection of hematopoietic stem cells or CLPs (9, 35). Although it has not been shown that the CLPs themselves migrate from the bone marrow to the thymus, it is possible that CLPs or one of their immediate offspring could migrate to and seed the thymus. We have previously reported that IL-7, which is presumably secreted from thymic epithelial cells, promotes survival of thymocytes undergoing positive selection through the up-regulation of Bcl-2 (1, 4). IL-7 is essential also for Ig gene rearrangement in developing B cells (5). Because IL-7 is known to exist in the thymic milieu, IL-7 would be available for the intrathymic development of B cells as well as T cells (36). Therefore, the thymic microenvironment should be able to physiologically support B lymphopoiesis as well as T lymphopoiesis.

Recent studies have shown that, in CD3-ε transgenic mice (37) and Notch1-deficient mice (38), the number of thymic B cells significantly increases in association with severe impairment of thymic T cell development. It is possible that alterations of these genes could skew the commitment of immature thymic progenitors toward the B cell lineage (37, 38). However, we demonstrate in this study that the disruption of T cell development simply by a TCRβ gene knockout also results in a relative and absolute increase in thymic B cell compartments. Accordingly, these data collectively suggest that in normal thymi, rapid expansion of T cells might take up most of the microenvironmental niches, preventing efficient thymic B cell maturation.

The presence of B cell development in and export from the thymus has potential implications for the immune system. For example, B cells that develop in the thymus may have a different repertoire of Ig receptors than do bone marrow-derived B cells, resulting from local Ags and stimuli mediating their positive and negative selection. This may allow a more diverse set of Ig receptors in the periphery. It is also possible that the thymic B cells may contribute to the cellular interactions that mediate positive and negative selection of maturing T cells (39), including Ig isotype and idiotype as selecting elements (40). Thus, it is important to clarify the role of these ectopically but physiologically developed thymic B cells in the immune system.

Acknowledgments

We thank L. Jerabek for capable laboratory management, L. Hidalgo and B. Lavarro for animal care, V. Braunstein for Ab preparation, and D. Dalma-Weiszhausz for critically reviewing the manuscript.

Footnotes

  • ↵1 This work was supported by U.S. Public Health Service Grant CA42551 (to I.L.W.) and by a grant from the Jose Carreras International Leukemia Society (to K.A.). L.I.R. is a Howard Hughes Medical Institute predoctoral fellow, and a Stanford Graduate Fellow.

  • ↵2 Address correspondence and reprint requests to Dr. Koichi Akashi at the current address: Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Sm 770B, 44 Binney Street, Boston, MA 02115. E-mail address: Koichi_akashi{at}dfci.harvard.edu

  • ↵3 K.A. and L.I.R. contributed equally to the research described in this paper.

  • ↵4 Abbreviations used in this paper: CLP, common lymphoid progenitor; RTE, recent thymic emigrants.

  • Received August 30, 1999.
  • Accepted February 25, 2000.

References

  1. ↵
    Akashi, K., M. Kondo, U. von Freeden-Jeffry, R. Murray, I. L. Weissman. 1997. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89: 1033
    OpenUrlCrossRefPubMed
  2. ↵
    Maraskovsky, E., L. A. O’Reilly, M. Teepe, L. M. Corcoran, J. J. Peschon, A. Strasser. 1997. Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1−/− mice. Cell 89: 1011
    OpenUrlCrossRefPubMed
  3. ↵
    Corcoran, A. E., F. M. Smart, R. J. Cowling, T. Crompton, M. J. Owen, A. R. Venkitaraman. 1996. The interleukin-7 receptor α chain transmits distinct signals for proliferation and differentiation during B lymphopoiesis. EMBO J. 15: 1924
    OpenUrlPubMed
  4. ↵
    Kondo, M., K. Akashi, J. Domen, K. Sugamura, I. L. Weissman. 1997. Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common γ chain-deficient mice. Immunity 7: 155
    OpenUrlCrossRefPubMed
  5. ↵
    Corcoran, A. E., A. Riddell, D. Krooshoop, A. R. Venkitaraman. 1998. Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature 391: 904
    OpenUrlCrossRefPubMed
  6. ↵
    Peault, B., I. Khazaal, I. L. Weissman. 1994. In vitro development of B cells and macrophages from early mouse fetal thymocytes. Eur. J. Immunol. 24: 781
    OpenUrlCrossRefPubMed
  7. ↵
    Kawamoto, H., K. Ohmura, Y. Katsura. 1998. Presence of progenitors restricted to T, B, or myeloid lineage, but absence of multipotent stem cells, in the murine fetal thymus. J. Immunol. 161: 3799
    OpenUrlAbstract/FREE Full Text
  8. ↵
    McKenna, H. J., P. J. Morrissey. 1998. Flt3 ligand plus IL-7 supports the expansion of murine thymic B cell progenitors that can mature intrathymically. J. Immunol. 160: 4801
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Kondo, M., I. L. Weissman, K. Akashi. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91: 661
    OpenUrlCrossRefPubMed
  10. ↵
    Wu, L., M. Antica, G. R. Johnson, R. Scollay, K. Shortman. 1991. Developmental potential of the earliest precursor cells from the adult mouse thymus. J. Exp. Med. 174: 1617
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Matsuzaki, Y., J. Gyotoku, M. Ogawa, S. Nishikawa, Y. Katsura, G. Gachelin, H. Nakauchi. 1993. Characterization of c-kit positive intrathymic stem cells that are restricted to lymphoid differentiation. J. Exp. Med. 178: 1283
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Wu, L., C. L. Li, K. Shortman. 1996. Thymic dendritic cell precursors: relationship to the T lymphocyte lineage and phenotype of the dendritic cell progeny. J. Exp. Med. 184: 903
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Mombaerts, P., A. R. Clarke, M. A. Rudnicki, J. Iacomini, S. Itohara, J. J. Lafaille, L. Wang, Y. Ichikawa, R. Jaenisch, M. L. Hooper, et al 1992. Mutations in T-cell antigen receptor genes α and β block thymocyte development at different stages. Nature 360: 225
    OpenUrlCrossRefPubMed
  14. ↵
    Scollay, R. G., E. C. Butcher, I. L. Weissman. 1980. Thymus cell migration: quantitative aspects of cellular traffic from the thymus to the periphery in mice. Eur. J. Immunol. 10: 210
    OpenUrlCrossRefPubMed
  15. ↵
    Gutman, G. A., I. L. Weissman. 1972. Lymphoid tissue architecture: experimental analysis of the origin and distribution of T-cells and B-cells. Immunology 23: 465
    OpenUrlPubMed
  16. ↵
    Small, M., W. Van Ewijk, A. M. Gown, R. V. Rouse. 1989. Identification of subpopulations of mouse thymic epithelial cells in culture. Immunology 68: 371
    OpenUrlPubMed
  17. ↵
    Adams, B., P. Dorfler, A. Aguzzi, Z. Kozmik, P. Urbanek, I. Maurer-Fogy, M. Busslinger. 1992. Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev. 6: 1589
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Rolink, A., E. ten Boekel, F. Melchers, D. T. Fearon, I. Krop, J. Andersson. 1996. A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors. J. Exp. Med. 183: 187
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Delassus, S., I. Titley, T. Enver. 1999. Functional and molecular analysis of hematopoietic progenitors derived from the aorta-gonad-mesonephros region of the mouse embryo. Blood 94: 1495
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Akashi, K., M. Kondo, I. L. Weissman. 1998. Two distinct pathways of positive selection for thymocytes. Proc. Natl. Acad. Sci. USA 95: 2486
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Butcher, E. C., I. L. Weissman. 1980. Direct fluorescent labeling of cells with fluorescein or rhodamine isothiocyanate. I. Technical aspects. J. Immunol. Methods 37: 97
    OpenUrlCrossRefPubMed
  22. ↵
    Akashi, K., I. L. Weissman. 1996. The c-kit+ maturation pathway in mouse thymic T cell development: lineages and selection. Immunity 5: 147
    OpenUrlCrossRefPubMed
  23. ↵
    Scollay, R., D. I. Godfrey. 1995. Thymic emigration: conveyor belts or lucky dips?. Immunol. Today 16: 268
    OpenUrlCrossRefPubMed
  24. ↵
    Surh, C. D., J. Sprent. 1994. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372: 100
    OpenUrlCrossRefPubMed
  25. ↵
    Kelly, K. A., M. Pearse, L. Lefrancois, R. Scollay. 1993. Emigration of selected subsets of γδ+ T cells from the adult murine thymus. Int. Immunol. 5: 331
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Michie, S. A., E. A. Kirkpatrick, R. V. Rouse. 1988. Rare peripheral T cells migrate to and persist in normal mouse thymus. J. Exp. Med. 168: 1929
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Agus, D. B., C. D. Surh, J. Sprent. 1991. Reentry of T cells to the adult thymus is restricted to activated T cells. J. Exp. Med. 173: 1039
    OpenUrlAbstract/FREE Full Text
  28. ↵
    Mori, S., M. Inaba, A. Sugihara, S. Taketani, H. Doi, Y. Fukuba, Y. Yamamoto, Y. Adachi, K. Inaba, S. Fukuhara, S. Ikehara. 1997. Presence of B cell progenitors in the thymus. J. Immunol. 158: 4193
    OpenUrlAbstract
  29. ↵
    Hardy, R. R., C. E. Carmack, S. A. Shinton, J. D. Kemp, K. Hayakawa. 1991. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173: 1213
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Miyama-Inaba, M., S. Kuma, K. Inaba, H. Ogata, H. Iwai, R. Yasumizu, S. Muramatsu, R. M. Steinman, S. Ikehara. 1988. Unusual phenotype of B cells in the thymus of normal mice. J. Exp. Med. 168: 811
    OpenUrlAbstract/FREE Full Text
  31. ↵
    Inaba, M., K. Inaba, Y. Adachi, K. Nango, H. Ogata, S. Muramatsu, S. Ikehara. 1990. Functional analyses of thymic CD5+ B cells: responsiveness to major histocompatibility complex class II-restricted T blasts but not to lipopolysaccharide or anti-IgM plus interleukin 4. J. Exp. Med. 171: 321
    OpenUrlAbstract/FREE Full Text
  32. ↵
    Weissman, I. L.. 1973. Thymus cell maturation: studies on the origin of cortisone-resistant thymic lymphocytes. J. Exp. Med. 137: 504
    OpenUrlAbstract
  33. ↵
    Dejbakhsh-Jones, S., L. Jerabek, I. L. Weissman, S. Strober. 1995. Extrathymic maturation of αβ T cells from hemopoietic stem cells. J. Immunol. 155: 3338
    OpenUrlAbstract
  34. ↵
    Garcia-Ojeda, M. E., S. Dejbakhsh-Jones, I. L. Weissman, S. Strober. 1998. An alternate pathway for T cell development supported by the bone marrow microenvironment: recapitulation of thymic maturation. J. Exp. Med. 187: 1813
    OpenUrlAbstract/FREE Full Text
  35. ↵
    Spangrude, G. J., R. Scollay. 1990. Differentiation of hematopoietic stem cells in irradiated mouse thymic lobes: kinetics and phenotype of progeny. J. Immunol. 145: 3661
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Montecino-Rodriguez, E., A. Johnson, K. Dorshkind. 1996. Thymic stromal cells can support B cell differentiation from intrathymic precursors. J. Immunol. 156: 963
    OpenUrlAbstract
  37. ↵
    Tokoro, Y., T. Sugawara, H. Yaginuma, H. Nakauchi, C. Terhorst, B. Wang, Y. Takahama. 1998. A mouse carrying genetic defect in the choice between T and B lymphocytes. J. Immunol. 161: 4591
    OpenUrlAbstract/FREE Full Text
  38. ↵
    Radtke, F., A. Wilson, G. Stark, M. Bauer, J. van Meerwijk, H. R. MacDonald, M. Aguet. 1999. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10: 547
    OpenUrlCrossRefPubMed
  39. ↵
    Inaba, M., K. Inaba, M. Hosono, T. Kumamoto, T. Ishida, S. Muramatsu, T. Masuda, S. Ikehara. 1991. Distinct mechanisms of neonatal tolerance induced by dendritic cells and thymic B cells. J. Exp. Med. 173: 549
    OpenUrlAbstract/FREE Full Text
  40. ↵
    Avery, A. C., Z. S. Zhao, A. Rodriguez, E. K. Bikoff, M. Soheilian, C. S. Foster, H. Cantor. 1995. Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide. Nature 376: 431
    OpenUrlCrossRefPubMed
Back to top

In this issue

The Journal of Immunology: 164 (10)
The Journal of Immunology
Vol. 164, Issue 10
15 May 2000
Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section